Byrne, James D.
Botticello, Thomas
Niemierko, Andrzej
Shih, Helen A.
Loeffler, Jay S.
Oh, Kevin S.
Article History
Received: 5 December 2019
Accepted: 23 March 2020
First Online: 14 April 2020
Competing interests
: Author J.B. owns stock in company, Advanced Chemotherapy Technologies, which has no relationship to the current work. Author H.S. serves on an Advisory Board for Genentech. Author T.B. declares that he has no conflicts of interest. Author A.N. declares that he has no conflicts of interest. Author J.L. declares that he has no conflicts of interest. Author K.O. received research funding from Merck & Co., Inc. for clinical trials on immune therapy and brain metastases and Elekta for research on a multi-institutional brain metastases consortium.